Kieran L Quinn1,2,3,4, Mohammed Shurrab2,3,5,6, Kevin Gitau1, Dio Kavalieratos7, Sarina R Isenberg8,9, Nathan M Stall3,10,11, Therese A Stukel2,3, Russell Goldman8,9, Daphne Horn4, Peter Cram1,2,3,4, Allan S Detsky1,3,4, Chaim M Bell1,2,3,4. 1. Department of Medicine, University of Toronto, Toronto, Ontario, Canada. 2. ICES, Toronto, Ottawa and North, Ontario, Canada. 3. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada. 4. Department of Medicine, Sinai Health System, Toronto, Ontario, Canada. 5. Health Sciences North Research Institute, Sudbury, Ontario, Canada. 6. Northern Ontario School of Medicine, Laurentian University, Sudbury, Ontario, Canada. 7. Division of Palliative Medicine, Department of Family and Preventive Medicine, Emory University, Atlanta, Georgia. 8. Temmy Latner Centre for Palliative Care and Lunenfeld-Tanenbaum Research Institute, Toronto, Ontario, Canada. 9. Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada. 10. Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada. 11. Division of Geriatric Medicine, University of Toronto, Toronto, Ontario, Canada.
Abstract
Importance: The evidence for palliative care exists predominantly for patients with cancer. The effect of palliative care on important end-of-life outcomes in patients with noncancer illness is unclear. Objective: To measure the association between palliative care and acute health care use, quality of life (QOL), and symptom burden in adults with chronic noncancer illnesses. Data Sources: MEDLINE, Embase, CINAHL, PsycINFO, and PubMed from inception to April 18, 2020. Study Selection: Randomized clinical trials of palliative care interventions in adults with chronic noncancer illness. Studies involving at least 50% of patients with cancer were excluded. Data Extraction and Synthesis: Two reviewers independently screened, selected, and extracted data from studies. Narrative synthesis was conducted for all trials. All outcomes were analyzed using random-effects meta-analysis. Main Outcomes and Measures: Acute health care use (hospitalizations and emergency department use), disease-generic and disease-specific quality of life (QOL), and symptoms, with estimates of QOL translated to units of the Functional Assessment of Chronic Illness Therapy-Palliative Care scale (range, 0 [worst] to 184 [best]; minimal clinically important difference, 9 points) and symptoms translated to units of the Edmonton Symptom Assessment Scale global distress score (range, 0 [best] to 90 [worst]; minimal clinically important difference, 5.7 points). Results: Twenty-eight trials provided data on 13 664 patients (mean age, 74 years; 46% were women). Ten trials were of heart failure (n = 4068 patients), 11 of mixed disease (n = 8119), 4 of dementia (n = 1036), and 3 of chronic obstructive pulmonary disease (n = 441). Palliative care, compared with usual care, was statistically significantly associated with less emergency department use (9 trials [n = 2712]; 20% vs 24%; odds ratio, 0.82 [95% CI, 0.68-1.00]; I2 = 3%), less hospitalization (14 trials [n = 3706]; 38% vs 42%; odds ratio, 0.80 [95% CI, 0.65-0.99]; I2 = 41%), and modestly lower symptom burden (11 trials [n = 2598]; pooled standardized mean difference (SMD), -0.12; [95% CI, -0.20 to -0.03]; I2 = 0%; Edmonton Symptom Assessment Scale score mean difference, -1.6 [95% CI, -2.6 to -0.4]). Palliative care was not significantly associated with disease-generic QOL (6 trials [n = 1334]; SMD, 0.18 [95% CI, -0.24 to 0.61]; I2 = 87%; Functional Assessment of Chronic Illness Therapy-Palliative Care score mean difference, 4.7 [95% CI, -6.3 to 15.9]) or disease-specific measures of QOL (11 trials [n = 2204]; SMD, 0.07 [95% CI, -0.09 to 0.23]; I2 = 68%). Conclusions and Relevance: In this systematic review and meta-analysis of randomized clinical trials of patients with primarily noncancer illness, palliative care, compared with usual care, was statistically significantly associated with less acute health care use and modestly lower symptom burden, but there was no significant difference in quality of life. Analyses for some outcomes were based predominantly on studies of patients with heart failure, which may limit generalizability to other chronic illnesses.
Importance: The evidence for palliative care exists predominantly for patients with cancer. The effect of palliative care on important end-of-life outcomes in patients with noncancer illness is unclear. Objective: To measure the association between palliative care and acute health care use, quality of life (QOL), and symptom burden in adults with chronic noncancer illnesses. Data Sources: MEDLINE, Embase, CINAHL, PsycINFO, and PubMed from inception to April 18, 2020. Study Selection: Randomized clinical trials of palliative care interventions in adults with chronic noncancer illness. Studies involving at least 50% of patients with cancer were excluded. Data Extraction and Synthesis: Two reviewers independently screened, selected, and extracted data from studies. Narrative synthesis was conducted for all trials. All outcomes were analyzed using random-effects meta-analysis. Main Outcomes and Measures: Acute health care use (hospitalizations and emergency department use), disease-generic and disease-specific quality of life (QOL), and symptoms, with estimates of QOL translated to units of the Functional Assessment of Chronic Illness Therapy-Palliative Care scale (range, 0 [worst] to 184 [best]; minimal clinically important difference, 9 points) and symptoms translated to units of the Edmonton Symptom Assessment Scale global distress score (range, 0 [best] to 90 [worst]; minimal clinically important difference, 5.7 points). Results: Twenty-eight trials provided data on 13 664 patients (mean age, 74 years; 46% were women). Ten trials were of heart failure (n = 4068 patients), 11 of mixed disease (n = 8119), 4 of dementia (n = 1036), and 3 of chronic obstructive pulmonary disease (n = 441). Palliative care, compared with usual care, was statistically significantly associated with less emergency department use (9 trials [n = 2712]; 20% vs 24%; odds ratio, 0.82 [95% CI, 0.68-1.00]; I2 = 3%), less hospitalization (14 trials [n = 3706]; 38% vs 42%; odds ratio, 0.80 [95% CI, 0.65-0.99]; I2 = 41%), and modestly lower symptom burden (11 trials [n = 2598]; pooled standardized mean difference (SMD), -0.12; [95% CI, -0.20 to -0.03]; I2 = 0%; Edmonton Symptom Assessment Scale score mean difference, -1.6 [95% CI, -2.6 to -0.4]). Palliative care was not significantly associated with disease-generic QOL (6 trials [n = 1334]; SMD, 0.18 [95% CI, -0.24 to 0.61]; I2 = 87%; Functional Assessment of Chronic Illness Therapy-Palliative Care score mean difference, 4.7 [95% CI, -6.3 to 15.9]) or disease-specific measures of QOL (11 trials [n = 2204]; SMD, 0.07 [95% CI, -0.09 to 0.23]; I2 = 68%). Conclusions and Relevance: In this systematic review and meta-analysis of randomized clinical trials of patients with primarily noncancer illness, palliative care, compared with usual care, was statistically significantly associated with less acute health care use and modestly lower symptom burden, but there was no significant difference in quality of life. Analyses for some outcomes were based predominantly on studies of patients with heart failure, which may limit generalizability to other chronic illnesses.
Authors: Louise Brereton; Joseph Clark; Christine Ingleton; Clare Gardiner; Louise Preston; Tony Ryan; Elizabeth Goyder Journal: Palliat Med Date: 2017-04-05 Impact factor: 4.762
Authors: Natalie C Ernecoff; Devon Check; Megan Bannon; Laura C Hanson; James Nicholas Dionne-Odom; Jennifer Corbelli; Michele Klein-Fedyshin; Yael Schenker; Camilla Zimmermann; Robert M Arnold; Dio Kavalieratos Journal: J Palliat Med Date: 2019-10-23 Impact factor: 2.947
Authors: Richard Brumley; Susan Enguidanos; Paula Jamison; Rae Seitz; Nora Morgenstern; Sherry Saito; Jan McIlwane; Kristine Hillary; Jorge Gonzalez Journal: J Am Geriatr Soc Date: 2007-07 Impact factor: 5.562
Authors: Morag C Farquhar; A Toby Prevost; Paul McCrone; Barbara Brafman-Price; Allison Bentley; Irene J Higginson; Chris J Todd; Sara Booth Journal: Trials Date: 2016-04-04 Impact factor: 2.279
Authors: Komal P Murali; Gary Yu; John D Merriman; Allison Vorderstrasse; Amy S Kelley; Abraham A Brody Journal: West J Nurs Res Date: 2021-08-25 Impact factor: 1.967
Authors: Mary Pilar Ingle; Devon Check; Daniel Hogan Slack; Sarah H Cross; Natalie C Ernecoff; Daniel D Matlock; Dio Kavalieratos Journal: J Pain Symptom Manage Date: 2021-10-29 Impact factor: 3.612
Authors: William E Rosa; Harleah G Buck; Allison P Squires; Sharon L Kozachik; Huda Abu-Saad Huijer; Marie Bakitas; Juli McGowan Boit; Patricia K Bradley; Pamela Z Cacchione; Garrett K Chan; Nigel Crisp; Constance Dahlin; Pat Daoust; Patricia M Davidson; Sheila Davis; Myrna A A Doumit; Regina M Fink; Keela A Herr; Pamela S Hinds; Tonda L Hughes; Viola Karanja; Deborah J Kenny; Cynthia R King; Hester C Klopper; Ann R Knebel; Ann E Kurth; Elizabeth A Madigan; Pamela Malloy; Marianne Matzo; Polly Mazanec; Salimah H Meghani; Todd B Monroe; Patricia J Moreland; Judith A Paice; J Craig Phillips; Cynda H Rushton; Judith Shamian; Mona Shattell; Julia A Snethen; Connie M Ulrich; Dorothy Wholihan; Lucia D Wocial; Betty R Ferrell Journal: Nurs Outlook Date: 2021-10-06 Impact factor: 3.250
Authors: Kathleen Oare Lindell; Sara Jo Klein; Melinda S Veatch; Kevin F Gibson; Daniel J Kass; Mehdi Nouraie; Margaret Q Rosenzweig Journal: Ann Am Thorac Soc Date: 2021-11
Authors: William E Rosa; Katherine I Pettus; Liliana De Lima; Allison Silvers; Stacie Sinclair; Lukas Radbruch Journal: J Palliat Med Date: 2021-04-30 Impact factor: 2.947